Non-invasive assessment of liver fibrosis by stiffness measurement in patients with chronic hepatitis B

Liver International

Volumn 29, Issue 2, 2009, Pages 242-247

  Marcellin, Patrick ^a   Ziol, Marianne ^b,c   Bedossa, Pierre ^a   Douvin, Catherine ^d   Poupon, Raoul ^e   De Lédinghen, Victor ^f   Beaugrand, Michel ^b,c  

^a BEAUJON HOSPITAL   (France)

^b UNIVERSITÉ PARIS 13   (France)

^c HÔPITAL JEAN VERDIER   (France)

^d HENRI MONDOR HOSPITAL   (France)

^e HÔPITAL SAINT ANTOINE   (France)

^f HAUT LÉVÊQUE HOSPITAL   (France)

Author keywords

Chronic hepatitis B; Fibrosis; Liver biopsy; Liver stiffness; Transient elastography

Indexed keywords

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE CLASSIFICATION; ELASTOGRAPHY; HEPATITIS B; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER EXAMINATION; LIVER FIBROSIS; LIVER STIFFNESS MEASUREMENT; MAJOR CLINICAL STUDY; MULTICENTER STUDY; NON INVASIVE MEASUREMENT;

ELASTICITY IMAGING TECHNIQUES; HEPATITIS B, CHRONIC; HUMANS; LIVER; LIVER CIRRHOSIS; PROSPECTIVE STUDIES;

EID: 58149510576     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2008.01802.x     Document Type: Article

References (33)

1. Bravo AA, Sheth S, Chpra S. Liver biopsy. N Engl J Med 2001; 344: 495-500.
2. Castera L, Negre I, Samii K, Buffet C. Pain experienced during percutaneous liver biopsy. Hepatology 1999; 30: 1529-30.
3. Cadranel JF, Rufat P, Degos F. Practices of liver biopsy in France: results of a prospective nationwide survey. For the Group of Epidemiology of the French Association for the Study of the Liver (AFEF). Hepatology 2000; 32: 477-81.
4. Colloredo G, Giuido M, Sonzogni A, Leandro G. Impact of liver biopsy size on histological evaluation of chronic viral hepatitis: The smaller the sample, the milder the disease. J Hepatol 2003; 39: 239-44.
5. Regev A, Berho M, Jeffers LJ, et al. Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol 2002; 97: 2614-8.
6. Siddique I, El-Naga HA, Madda JP, Memon A, Hasan F. Sampling variability on percutaneous liver biopsy in patients with chronic hepatitis C virus infection. Scand J Gastroenterol 2003; 38 (Suppl.): 427-32.
7. Aube C, Oberti F, Korali N, et al. Ultrasonographic diagnosis of hepatic fibrosis or cirrhosis. J Hepatol 1999; 30: 472-8.
8. Nishiura T, Watanabe H, Ito M, et al. Ultrasound evaluation of the fibrosis stage in chronic liver disease by the simultaneous use of low and high frequency probes. Br J Radiol 2005; 78: 189-97.
9. Croquet V, Vuillemin E, Ternisien C, et al. Prothrombin index is an indirect marker of severe liver fibrosis. Eur J Gastroenterol Hepatol 2002; 14: 1133-41.
10. Forns X, Ampurdanes S, Llovet JM, et al. Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model. Hepatology 2002; 36: 986-92.
11. Wai CT, Greenson JK, Fontana RJ, et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 2003; 38: 518-26.
12. Rockey DC, Bissell DM. Noninvasive measures of liver fibrosis. Hepatology 2006; 43: S113-20.
13. Halfon P, Bacq Y, De Muret A, et al. Comparison of test performance profile for blood tests of liver fibrosis in chronic hepatitis C. J Hepatol 2007; 46: 395-402.
14. Castera L, Vergniol J, Foucher J, et al. Prospective comparison of transient elastography, fibrotest, APRI and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology 2005; 128: 343-50.
15. Colletta C, Smirne C, Fabris C, et al. Value of two noninvasive methods to detect progression of fibrosis among HCV carriers with normal aminotransferases. Hepatology 2005; 42: 838-45.
16. Ziol M, Handra-Luca A, Kettaneh A, et al. Non-invasive assessment of liver fibrosis by stiffness measurement: A prospective multicentre study in patients with chronic hepatitis C. Hepatology 2005; 41: 48-54.
17. de Ledinghen V, Douvin C, Kettaneh A, et al. Diagnosis of hepatic fibrosis and cirrhosis by transient elastography (FibroScan ®) in HIV-hepatitis C virus-coinfected patients. J Acquir Immune Defic Syndr 2006; 41: 175-9.
18. Corpechot C, El Naggar A, Poujol-Robert A, et al. Assessment of biliary fibrosis by transient elastography in patients with PBC and PSC. Hepatology 2006; 43: 1118-24.
19. Foucher J, Chanteloup E, Castera L, et al. Diagnosis of cirrhosis and its complications by transient elastography (FibroScan ®): A prospective study. Gut 2005; 55: 403-8.
20. Ganne-Carrie N, Ziol M, de Ledinghen V, et al. Accuracy of liver stiffness measurement for the diagnosis of cirrhosis in patients with chronic liver diseases. Hepatology 2006; 44: 1511-7.
21. Sandrin L, Fourquet B, Hasquenoph JM, et al. Transient elastography: A new non-invasive method for assessment of hepatic fibrosis. Ultrasound Med Biol 2003; 29: 1705-13.
22. Bedossa P, Poynard T. An algorithm for the grading of activity in chronic hepatitis C. Hepatology 1996; 24: 289-93.
23. Ishak K, Baptista A, Bianchi L, et al. Histological grading and staging of chronic hepatitis. J Hepatol 1995; 22: 696-9.
24. Foucher J, Castera L, Bernard PH, et al. Prevalence and factors associated with failure of liver stiffness measurement using FibroScan ® in a prospective study of 2114 examinations. Eur J Gastroenterol Hepatol 2006; 18: 411-2.
25. Fraquelli M, Rigamonti C, Casazza G, et al. Reproducibility of transient elastography in the evaluation of liver fibrosis in patients with chronic liver disease. Gut 2007; 56: 968-73.
26. Konate A, Boursier J, Reaud S, et al. Liver stiffness measurement by transient elastography: Predictive factors of accuracy, success and reproducibility (abstract). 57th Annual Meeting of the American Association for the Study of Liver Diseases 2006, Boston, MA, USA.
27. Maharaj B, Maharaj RJ, Leary WP, et al. Sampling variability and its influence on the diagnostic yield of percutaneous needle biopsy of the liver. Lancet 1986; 1: 523-5.
28. Abdi W, Millan JC, Mezey E. Sampling variability on percutaneous liver biopsy. Arch Intern Med 1979; 139: 667-9.
29. Bedossa P, Dargere D, Paradis V. Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology 2003; 38: 1449-57.
30. Rousselet MC, Michalak S, Dupre F, et al. Sources of variability in histological scoring of chronic viral hepatitis. Hepatology 2005; 41: 257-64.
31. Sagir A, Erhardt A, Schmitt M, et al. Transient elastography is unreliable for detection of cirrhosis in patients with acute liver damage. Hepatology 2008; 47: 592-5.
32. Arena U, Vizzutti F, Corti G, et al. Acute viral hepatitis increases liver stiffness values measured by transient elastography. Hepatology 2008; 47: 380-4.
33. Coco B, Oliveri F, Maina AM, et al. Transient elastography: A new surrogate marker of liver fibrosis influenced by major changes of transaminases. J Viral Hepat 2007; 14: 360-9.